Symbol Therapeutics Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
Symbol Therapeutics General Information
Description
Developer of novel immunoregulatory therapeutic protein designed to restore immune balance for autoimmune diseases. The company's protein can activate anti-inflammatory regulatory mechanisms and restore normal immune homeostasis, enabling medical professionals to treat autoimmune disorders effectively.
Contact Information
Corporate Office
- House Number 2, Ramon Ilan
- Ness Ziona 7403635
- Israel
Corporate Office
- House Number 2, Ramon Ilan
- Ness Ziona 7403635
- Israel
Symbol Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 10-Nov-2025 | Completed | Bankruptcy: Liquidation | |||
| 1. Seed Round | 01-Sep-2022 | Completed | Startup |
Symbol Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Symbol Therapeutics FAQs
-
When was Symbol Therapeutics founded?
Symbol Therapeutics was founded in 2021.
-
Where is Symbol Therapeutics headquartered?
Symbol Therapeutics is headquartered in Ness Ziona, Israel.
-
What industry is Symbol Therapeutics in?
Symbol Therapeutics’s primary industry is Drug Discovery.
-
Is Symbol Therapeutics a private or public company?
Symbol Therapeutics is a Private company.
-
What is Symbol Therapeutics’s current revenue?
The current revenue for Symbol Therapeutics is .
-
How much funding has Symbol Therapeutics raised over time?
Symbol Therapeutics has raised $3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
